Aprepitant Restores Corneal Sensitivity and Reduces Pain in DED.

Authors:
Bonelli F; Campestre F; Lasagni Vitar RM; Demirsoy IH; Fonteyne P and 1 more

Journal:
Transl Vis Sci Technol

Publication Year: 2024

DOI:
10.1167/tvst.13.2.9

PMCID:
PMC10866158

PMID:
38345550

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Transl Vis Sci Technol

Abbreviation: Transl Vis Sci Technol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biomedical Engineering

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A Bayesian Hierarchical Spatial Longitudinal Model Improves Estimation of Local Macular Rates of Ch…
Su E; Mohammadzadeh V; Mohammadi M and 6 more (2024) - Transparency Score: 3/6
Acanthamoeba Keratitis in China: Genotypic and Clinical Correlations.
Pang J; Wei Z; Wang L and 14 more (2024) - Transparency Score: 3/6
A Catalog of Patent Applications Published in 2023 Related to Ophthalmology and Vision Science.
Stern G; Mallett JJ. (2024) - Transparency Score: 1/6
Acrizanib as a Novel Therapeutic Agent for Fundus Neovascularization via Inhibitory Phosphorylation…
Tang X; Cui K; Wu P and 8 more (2024) - Transparency Score: 3/6
Are Macula or Optic Nerve Head Structures Better at Diagnosing Glaucoma? An Answer Using Artificial…
Chiang CYN; Braeu FA; Chuangsuwanich T and 6 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure: F. Bonelli, None; F. Campestre, None; R.M. Lasagni Vitar, None; I.H. Demirsoy, None; P. Fonteyne, None; G. Ferrari, San Raffaele Hospital (F), filed patent describing the use of neurokinin 1 receptor antagonists for the treatment of ocular pain (P)"

Evidence found in paper:

"This study has been funded by Bausch & Lomb."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025